EOG
42
3
IPG
43
4
HON
45
-7
AIZ
56
-3
NRG
44
-3
KEY
70
3
AVGO
25
-2
THC
73
3
UA
38
6
EXPE
45
-3
SBUX
36
3
DAL
42
2
STX
57
-7
TMO
59
-7
MNST
70
14
OMC
54
7
DVN
35
2
WAT
49
-6
BSX
57
-6
CF
54
4
EOG
42
3
IPG
43
4
HON
45
-7
AIZ
56
-3
NRG
44
-3
KEY
70
3
AVGO
25
-2
THC
73
3
UA
38
6
EXPE
45
-3
SBUX
36
3
DAL
42
2
STX
57
-7
TMO
59
-7
MNST
70
14
OMC
54
7
DVN
35
2
WAT
49
-6
BSX
57
-6
CF
54
4
Financhill
Back

Janux Therapeutics Stock Predictions

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.
Sell
44

JANX
Janux Therapeutics

Last Price:
44.05
Seasonality Move:
-18.02%

7 Day Trial

ALL ACCESS PASS

$ 7

$1,300 into $45,000 in just 4 MONTHS?!

See here to see the full details.

Janux Therapeutics Stock Forecast

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 69.4% based on the past 3 years of stock performance.
  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Janux Therapeutics Stock Undervalued?
    The current Janux Therapeutics [JANX] share price is $42.76. The Score for JANX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 69.4% based on the past 3 years of stock performance.

Janux Therapeutics Stock Rating

Sell
44
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics overpriced?

  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

  • The current trend is moderately bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com

52-Week Data

52-Week High:
65.60
52-Week Low:
5.65

Prediction Charts

Market Cap:
2.22B
Price in USD:
42.76
Volume:
392.26K
Beta:
3.67

Technical Analysis

SMA50:
44.11
SMA100:
44.83
SMA200:
27.77
52-Wk Change:
224.19%

Stock Predictions

  • Is Janux Therapeutics stock public?
    Yes, Janux Therapeutics is a publicly traded company.
  • What is the Janux Therapeutics stock quote today?
    The Janux Therapeutics stock price is 42.76 USD today.
  • How to buy Janux Therapeutics stock online?
    You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-8 40.79 39.45 43.96 39.16
Jul-9 39.40 41.66 42.29 38.34
Jul-10 42.18 41.55 42.80 41.28
Jul-11 42.28 42.28 43.36 41.69
Jul-12 42.95 44.23 44.29 42.31
Jul-15 44.70 43.47 45.95 43.36
Jul-16 44.26 46.38 48.94 43.52
Jul-17 45.29 43.91 47.40 43.83
Jul-18 43.98 43.05 45.59 41.44
Jul-19 43.23 44.68 45.00 42.20
Jul-22 45.07 47.72 47.81 44.20
Jul-23 47.25 45.42 47.65 45.09
Jul-24 44.51 45.34 46.76 44.10
Jul-25 45.43 42.76 46.53 42.70

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.06 per share, an increase this year of $0.11 per share, and a decrease next year of $0.39 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.